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EFFICACY OF THE CONSUMPTION OF YOGURT
SUPPLEMENTED WITH A NATURAL EXTRACT CONTAINING
HYALURONIC ACID (MOBILEE™) IN ADULTS WITH MILDLY
JOINT DISCOMFORT - A PROSPECTIVE RANDOMIZED
DOUBLE-BLIND PLACEBO CONTROLLED TRIAL
D. Martinez-Puig1, I. Möller2, C. Fernández3, C. Chetrit1
1Bioiberica S.A., Palafolls, Spain; 2Inst. Poal de Reumatologia,
Barcelona, Spain; 3Inst. Univ. Dexeus, Barcelona, Spain
Purpose: The objective of the present study was to determine the
efﬁcacy of the oral administration of yogurts supplemented with
an extract rich in hylauronic acid in healthy individuals with mildly
joint discomfort.
Methods: A prospective doubled-blind randomized placebo-
controlled trial with 40 healthy individuals with joint discomfort
(VAS <4) was designed. The effect of oral supplementation with
a natural extract rich in hyaluronic acid (Mobilee™) included in a
yogurt matrix was evaluated on functional and quality of live pa-
rameters. The isokinetic Biodex system 3 for measuring maximal
muscle strength, total work and power mean was used. Partici-
pants were divided into two groups (n=20) who consumed daily a
yogurt supplemented with the extract or not supplemented during
a period of 90 days.
Results: The increase of the maximum peak torque of the knee
extensors respect basal value was 7.6±7.6 Nm for the supple-
mented and 2.5±4.7 Nm for the control group at 180°/s (P=0.0582)
and 6.5±5.8 Nm for the supplemented and -1.0±7.1 Nm for the
control group at 240°/s (P<0.05). The same pattern of response
was observed for total work with increases of 39.8±14.0 J for
the supplemented and 2.1±11.9 J for the control group at 240°/s
(P=0.0588) and for the power mean with increases of 16.6±6.1
W for the supplemented and -1.3±5.2 W for the control group
at 240°/s (P<0.05). Differences were less pronounced for the
knee ﬂexors. No differences were detected for Lequesne score
and SF-36 except for social functioning subscale at one month
follow-up.
Conclusions: This controlled prospective nutritional trial con-
ﬁrmed that 3 months oral consumption of a natural extract con-
taining hylauronic acid (Mobilee™) in healthy individuals with joint
discomfort of the knee provide improvements in muscular strength.
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NUTRITION AND KNEE OSTEOARTHRITIS IN
POSTMENOPAUSAL WOMEN
N.V. Grygorieva, V.V. Povoroznyuk
Inst. of Gerontology AMSU, Kyiv, Ukraine
Purpose: The purpose of this study was to determine the rela-
tionship of consumption of different nutrients in feeding ration of
ukrainian postmenopausal women and incident and stage of knee
osteoarthritis.
Methods: Inﬂuence of diets on development and progressing
of knee osteoarthritis was investigated in 133 postmenopausal
women. A diagnosis of knee osteoarthritis was performed by the
criteria of American Rheumatology Association (1995), its stage
- by Kellgren&Lawrence classiﬁcation. Consumption of different
macro- and micronutrients in daily feeding ration was analysed
with questionnaire (during three days).
Results: There are a literature data about possible inﬂuence of
some nutrients on the development and progressing of knee os-
teoarthritis. It was shown, that the patients with low level of vitamin
C in their blood had a triple progressing risk of osteoarthritis.
Famous properties of vitamins E and A also give a possibility to
think about their role in progressing of osteoarthritis. The patients
with low concentration of vitamin D in feeding ration have a raised
risk of knee osteoarthritis. We did not found the differences in
contents of most macro- and micronutrients in depend of incident
and stage of osteoarthritis, however it was a tendency in con-
sumption of some microelements and vitamins. The patients with
OA compared with control group have a more level of β-carotin
(F=2,64, P=0,11), folacin (F=2,94, P=0,09), less level of vitamin D
(accordingly 0,33±0,04 and 0,53±0,06; F=6,51, P=0,01). We have
not founded the differences in consumption of vitamin C (F=1,96,
P=0,16), vitamin A (F=0,05, P=0,83) and E (F=0,85, P=0,36) in
patients dependency on presence of arthritis. The quartiles anal-
ysis showed that frequency of knee osteoarthritis in women in
ﬁrst quartile of vitamin D consumption was 58,3 %, fourth quartile
- 31,4 %. We did not ﬁnd the reduction the frequencyof knee
osteoarthritis in postmenopausal women with different level of vi-
tamin C (I quartile - 50, II - 39, III - 37,5, IV - 47,6%) and E
(I quartile - 50, II - 40,8, III - 36,7, IV- 64,7% accordingly). We
detected some reduction the frequency of knee osteoarthritis in
patient with hight level of vitamin A (I quartile - 46,2, II - 50, III
- 42,9, IV- 28,5%) and B6 (I quartile - 71,4, II - 36,7, III -48,1,
IV- 41,7% accordingly).We have not founded the differences in
consumption of all macro- and micronutrients in depend of stage
of osteoarthritis.
Conclusions: Our results shows that in the feeding ration of
ukrainian postmenopausal women with knee osteoarthritis there
are signiﬁcant more level of vitamin D and diminished level of some
microelements and vitamins, that can contribute to its progressing.
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ANTI-INFLAMMATORY EFFECTS OF ORALLY INGESTED
COLLAGEN HYDROLYSATE OR GLYCINE
A. Hartog1,2, M. Cozijnsen1, E. Chiotelli3, J. Garssen1,2
1Danone Res., Ctr. for Specialised Nutrition, Wageningen,
Netherlands; 2Dept. of Pharmacology & Pathophysiology, Utrecht
Inst. for Pharmaceutical Sci. (UIPS), Utrecht, Netherlands;
3Danone Res., Ctr. Daniel Carasso, Palaiseau Cedex, France
Purpose: Collagen hydrolysate (CH) has been indicated to im-
prove joint comfort and function. It is suggested that the speciﬁc
amino acids derived from the collagen could reduce pain and
help to protect the joint in osteoarthritis (OA) patients. Glycine
comprises about one third of the amino acids in the collagen. It
has been shown that the free glycine levels in the blood increase
after ingestion of CH. Furthermore, preclinical studies indicate
an anti-inﬂammatory effectiveness of glycine. The present study
evaluates the anti-inﬂammatory capacity of CH and glycine.
Methods: Different amounts of CH (12.5, 25 and 50 mg/mouse)
and glycine (10, 20 and 50 mg/mouse) were administered orally
to Balb/C mice, aged 14 weeks. Inﬂammation was induced, 3 h
after administration of the test components, by injecting zymosan
(25 μl, 0.5% in PBS) intradermally in the ear. Ear-swelling, as
a measure for inﬂammatory response, was detected using an
engineer’s micrometer. Serum levels of glycine and LPS stimulated
production of IL-6 and TNF-α in whole blood or PBMC were
detected at 3 h after intake of the test components.
Osteoarthritis and Cartilage Vol. 17, Supplement 1 S277
Results: Both CH and glycine were able to counteract the
zymosan-induced ear swelling at 3 h after zymosan injection in
a concentration depending manner. This effect was accompanied
by a concentration dependent increase in the levels of free serum
glycine and a decrease in the production of pro-inﬂammatory cy-
tokines. The CH effects were less pronounced compared to the
glycine effects.
Conclusions: The present study indicates that CH is able to
display an anti-inﬂammatory activity. The reduction of pain by CH,
as indicated in several clinical studies in patients with OA, could
at least partially origin from the anti-inﬂammatory capacity of CH.
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A NOVEL BIOMECHANICAL DEVICE IMPROVES GAIT
PATTERNS AND CLINICAL MEASUREMENTS IN PATIENTS
WITH KNEE OSTEOARTHRITIS
A. Elbaz1, A. Mor1, G. Segal1, A. Haim2, E. Debbi1,
N. Halperin3, R. Debi3
1APOS Res. Group, Herzliya, Israel; 2Tel Aviv Sourasky Med. Ctr.,
Tel-Aviv, Israel; 3Asaf Ha’Rofe Med. Ctr., Zeriﬁn, Israel
Purpose: The management of knee Osteoarthritis (KOA) is
presently focused on reducing the level of pain and disability. Mus-
cle weakness and proprioception difﬁculties have been related to
KOA severity, level of pain and disability and are an integral focus
of the therapeutic program for KOA patients. A novel biomechan-
ical device (APOS system) designated to strengthen and train
neuromuscular control was shown to reduce knee adduction mo-
ment. The purpose of the current study was to investigate the
clinical effect of this biomechanical device on patients with KOA.
Methods: 47 patients with bilateral KOA were enrolled to the study.
Patient underwent a gait test and completed the WOMAC Index
and the SF-36 health survey at baseline and after 12 weeks. The
biomechanical device was individually calibrated to each patient
as to allow training under reduced pain. Patients were instructed
to walk with the device on a daily basis for a period of 12 weeks.
Spatio-temporal parameters were used to identify changes in gait
patterns and the questionnaires were used to identify changes in
the reported level of pain, function and quality of life.
Results: Gait velocity, step length and single limb support in-
creased signiﬁcantly following the 3 months of treatment (10%, 6%
Abstract 518 – Figure 1. Production of endogenous hyaluronic synthesis from human synoviocytes with varying intervention concentrations at two time periods.
and 1%, respectively). In addition, WOMAC-Pain and WOMAC-
Function signiﬁcantly decreased (22% and 24%, respectively),
and SF-36 score signiﬁcantly increased (14%) (P<0.001 for all
parameters).
Conclusions: Our results suggest an overall improvement in the
gait pattern, level of pain and functional condition of patients with
KOA following 12 weeks of treatment with the novel biomechanical
device.
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COMPARISON OF THE EFFICACY OF TWO PRODUCTS
SOLD AS ORALLY-ADMINSITERED HYLAURONIC ACID
SUPPLEMENTS, IB0004 AND ID386 ON THE ENDOGENOUS
IN VITRO SYNTHESIS OF HYALURONIC ACID BY HUMAN
SYNOVIOCYTES
A. Torrent1, R. Ruhí1, J. Theodosakis2, F. Blanco3
1Bioiberica, S.A., Barcelona, Spain; 2Univ. of Arizona, Tucson, AZ;
3Unidad de Investigación, CHU Juan Canalejo, A Coruña, Spain
Purpose: Hyaluronic acid (HA) is a heteropolysaccharide present
in synovial ﬂuid and in extracellular matrix of cartilage. HA is
synthesized by human synoviocytes and chondrocytes, and is re-
sponsible for the viscosity of articular synovial ﬂuid. Synovial ﬂuid
has mechanical properties and biochemical properties such as: 1)
Inhibition of prostaglandin E2 and synthesis of nitric oxide (NO)
induced by IL-1. 2) Protection against proteoglycan depletion. 3)
Protection against cytotoxicity induced by oxygen-derived free rad-
icals and NO-induced apoptosis. 4) Affects on leukocyte function.
5) The suppression of cartilage-matrix degradation. 6) Stimula-
tion of the synthesis of endogenous HA. In patients with OA,
the concentration of endogenous HA in synovial ﬂuid decreases
signiﬁcantly. Intra-articular administration of exogenous HA is a
therapeutic option currently in use to treat grades II-III knee OA
patients. We therefore conceived the present study, to ﬁnd out
whether the compounds IB0004 (a natural rooster comb extract
rich in HA) and ID386 (avian hydrolyzed collagen with low HA
content) stimulate the synthesis of endogenous hyaluronic acid in
human osteoarthritic synoviocytes.
Methods: To study the effect of IB0004 and ID386, Human syn-
oviocytes from OA synovial tissue were prepared by enzymatic
digestion, isolated, and cultivated in RPMI supplemented with 10%
